Search - tctmd.com

Displaying 1 - 7 of 7

Sort: Relevancy | Date

Presentation TCT 2023

TCT 593: Impact of Non-elective Weekend Admission on Outcomes of Percutaneous Coronary Intervention

Presenter: Nameer Ascandar

October 25, 2023

Presentation TCT 2018

Case #1: Percutaneous Closure of Anything With Something - The Off-Label Use of Devices. Mitral Leak, Post-MI VSD, Ascending Aorta Pseudoaneurysm, LV Pseudoaneurysm

Presenter: Joshua P. Loh, João A Silveira, Andres Jr N Baysa, Alexandre Schaan Quadros

September 23, 2018

Presentation TCT 2014

Case #2: Iatrogenic Ascending Aortic Dissection During Primary PCI with a Transradial Approach

Presenter: Mahmoud Hashemian, Ajay J. Kirtane, Mohammad Ali Ostovan, Hrvoje Pintaric, Josko Bulum

September 14, 2014

Presentation TCT 2012

Contrarian Position: ASCERT is Hopelessly Confounded. PCI Outcomes Are No Worse, and PCI Is More Widely Acceptable and Applicable!

Presenter: Christopher White

October 24, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: CORONARY (On-Pump vs. Off-Pump CABG), CPORT (Nonprimary PCI Without Surgical Backup), ASCERT (CABG vs. PCI), and TRAP2-TIMI 50 (Vorapaxar for...

Presenter: David Morrow

October 23, 2012

Presentation

Survival Analysis of Clinical Subsets from the ASCERT Study: CABG vs. PCI in Multivessel Disease

Presenter: Fred H. Edwards

February 02, 2012

Presentation

Análisis de Supervivencia de los Subgrupos Clínicos del Estudio ASCERT : CABG frente a PCI en la Enfermedad Multivaso

Presenter: Fred H. Edwards

February 02, 2012

Advertisement

TCT 593: Impact of Non-elective Weekend Admission on Outcomes of Percutaneous Coronary Intervention

Case #1: Percutaneous Closure of Anything With Something - The Off-Label Use of Devices. Mitral Leak, Post-MI VSD, Ascending Aorta Pseudoaneurysm, LV Pseudoaneurysm

Case #2: Iatrogenic Ascending Aortic Dissection During Primary PCI with a Transradial Approach

Contrarian Position: ASCERT is Hopelessly Confounded. PCI Outcomes Are No Worse, and PCI Is More Widely Acceptable and Applicable!

Late Breaking Clinical Trials: CORONARY (On-Pump vs. Off-Pump CABG), CPORT (Nonprimary PCI Without Surgical Backup), ASCERT (CABG vs. PCI), and TRAP2-TIMI 50 (Vorapaxar for...

Survival Analysis of Clinical Subsets from the ASCERT Study: CABG vs. PCI in Multivessel Disease

Análisis de Supervivencia de los Subgrupos Clínicos del Estudio ASCERT : CABG frente a PCI en la Enfermedad Multivaso

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content